NCT00845702View on ClinicalTrials.gov

Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

PHASE3TerminatedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Renal Artery Stenosis
Interventions
DRUG

Gadoterate meglumine (Dotarem)

Each subject will receive one injection of Dotarem 0.2 ml/kg

OTHER

Time of Flight Magnetic Resonance Angiography

Each subject will undergo a TOF MRA

Trial Locations (1)

47403

Guerbet LLC, Bloomington

Sponsors

Lead Sponsor

Guerbet
All Listed Sponsors
lead

Guerbet

INDUSTRY

NCT00845702 - Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF) | Biotech Hunter | Biotech Hunter